Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Levofloxacin 500mg tablets
0501120X0AAAAAA
|
Levofloxacin | Levofloxacin | Infections | 6,764 |
|
Levofloxacin 250mg tablets
0501120X0AAABAB
|
Levofloxacin | Levofloxacin | Infections | 1,392 |
|
Levofloxacin 5mg/ml eye drops
1103010AGAAAAAA
|
Levofloxacin (Eye) | Levofloxacin | Eye | 936 |
|
Levofloxacin 5mg/ml eye dps 0.3ml ud preservative free
1103010AGAAACAC
|
Levofloxacin (Eye) | Levofloxacin | Eye | 876 |
|
Levofloxacin 5mg/ml eye drops preservative free
1103010AGAAADAD
|
Levofloxacin (Eye) | Levofloxacin | Eye | 348 |
|
Oftaquix 5mg/ml eye drops 0.3ml unit dose
1103010AGBBACAC
|
Oftaquix | Levofloxacin | Eye | 211 |
|
Oftaquix 5mg/ml eye drops
1103010AGBBAAAA
|
Oftaquix | Levofloxacin | Eye | 172 |
|
Levofloxacin 5mg/ml eye dps 0.5ml ud preservative free
1103010AGAAABAB
|
Levofloxacin (Eye) | Levofloxacin | Eye | 130 |
|
Eyflox 5mg/ml eye drops
1103010AGBCAAAD
|
Eyflox | Levofloxacin | Eye | 21 |
|
Oxalux 5mg/ml eye drops 0.5ml unit dose
1103010AGBDAAAB
|
Oxalux | Levofloxacin | Eye | 6 |
|
Oftaquix 5mg/ml eye drops 0.5ml unit dose
1103010AGBBABAB
|
Oftaquix | Levofloxacin | Eye | 2 |
|
Evoxil 250mg tablets
0501120X0BCAAAB
|
Evoxil | Levofloxacin | Infections | No data available |
|
Evoxil 500mg tablets
0501120X0BCACAA
|
Evoxil | Levofloxacin | Infections | No data available |
|
Evoxil 500mg/100ml solution for infusion vials
0501120X0BCABAC
|
Evoxil | Levofloxacin | Infections | No data available |
|
Levofloxacin 100mg/ml nebuliser liquid ampoules
0501120X0AAAFAF
|
Levofloxacin | Levofloxacin | Infections | No data available |
|
Levofloxacin 500mg/100ml infusion bags
0501120X0AAADAD
|
Levofloxacin | Levofloxacin | Infections | No data available |
|
Levofloxacin 500mg/100ml infusion polyethylene bottles
0501120X0AAAGAG
|
Levofloxacin | Levofloxacin | Infections | No data available |
|
Levofloxacin 500mg/100ml solution for infusion bottles
0501120X0AAAEAE
|
Levofloxacin | Levofloxacin | Infections | No data available |
|
Levofloxacin 500mg/100ml solution for infusion vials
0501120X0AAACAC
|
Levofloxacin | Levofloxacin | Infections | No data available |
|
Quinsair 240mg nebuliser solution ampoules
0501120X0BDAAAF
|
Quinsair | Levofloxacin | Infections | No data available |
|
Tavanic 250mg tablets
0501120X0BBABAB
|
Tavanic | Levofloxacin | Infections | No data available |
|
Tavanic 500mg tablets
0501120X0BBAAAA
|
Tavanic | Levofloxacin | Infections | No data available |
|
Tavanic 500mg/100ml solution for infusion vials
0501120X0BBACAC
|
Tavanic | Levofloxacin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.